Kidney Cancer Journal | Volume 4, Issue 3
The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice...
Read MoreSelect Page
by Kidney Cancer Journal | Oct 2020
The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice...
Read Moreby Kidney Cancer Journal | Jul 2020
Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma Abstract With the...
Read Moreby Kidney Cancer Journal | Apr 2020
The Prognostic Value of DNA Methylation Markers in Renal Cell Cancer: A Systematic Review...
Read Moreby Kidney Cancer Journal | Nov 2019
Immune Checkpoint Inhibition, the Key to Success in Renal Cell Carcinoma?Treatment of renal cell...
Read Moreby Kidney Cancer Journal | Oct 2019
Genomic Instability in Kidney Cancer: Etiologies and Treatment Opportunities Genomic instability...
Read Moreby Kidney Cancer Journal | Aug 2019
The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the...
Read Moreby Kidney Cancer Journal | Apr 2019
Radiation Therapy for Renal Cell Carcinoma Radiation therapy (RT) has traditionally been...
Read Moreby Kidney Cancer Journal | Sep 2018
Partial Nephrectomy is the Surgical Treatment of Choice for (Most) Complex Localized Renal...
Read Moreby Kidney Cancer Journal | Apr 2018
Adjuvant Sunitinib for Renal Cell Carcinoma: Still at the Beginning of the RoadThe remarkable...
Read Moreby Thai H. Ho, MD, PhD | Apr 2015
Dr. Thai H. Ho spoke at the 23rd annual Perspectives in Urology: Point Counterpoint meeting on...
Read More